BioCentury 100 vs. broader market

The biotech sector was up 10% in the first half, as measured by the BioCentury 100 index. In comparison, the Dow Jones is unchanged, while the S&P 500 is up 3%. The tech-heavy NASDAQ was up 2% in the ...